QIAGEN N.V.
QGEN
$32.70
-$1.00-2.97%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 492.32M | 540.42M | 532.58M | 533.54M | 483.46M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 492.32M | 540.42M | 532.58M | 533.54M | 483.46M |
| Cost of Revenue | 168.83M | 173.92M | 187.78M | 185.95M | 161.29M |
| Gross Profit | 323.49M | 366.51M | 344.80M | 347.59M | 322.16M |
| SG&A Expenses | 142.39M | 153.88M | 143.11M | 148.75M | 137.94M |
| Depreciation & Amortization | 15.59M | 17.19M | 15.65M | 15.12M | 15.27M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 375.07M | 392.22M | 395.29M | 397.57M | 358.29M |
| Operating Income | 117.26M | 148.21M | 137.29M | 135.97M | 125.16M |
| Income Before Tax | 85.83M | 109.17M | 134.73M | 126.82M | 119.55M |
| Income Tax Expenses | 17.79M | 1.34M | 4.68M | 30.57M | 28.79M |
| Earnings from Continuing Operations | 68.04M | 107.83M | 130.04M | 96.25M | 90.76M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 68.04M | 107.83M | 130.04M | 96.25M | 90.76M |
| EBIT | 117.26M | 148.21M | 137.29M | 135.97M | 125.16M |
| EBITDA | 168.47M | 179.60M | 188.26M | 185.45M | 169.07M |
| EPS Basic | 0.33 | 0.52 | 0.63 | 0.47 | 0.44 |
| Normalized Basic EPS | 0.36 | 0.48 | 0.43 | 0.43 | 0.40 |
| EPS Diluted | 0.33 | 0.52 | 0.63 | 0.46 | 0.43 |
| Normalized Diluted EPS | 0.35 | 0.48 | 0.43 | 0.42 | 0.39 |
| Average Basic Shares Outstanding | 207.01M | 207.76M | 206.03M | 205.87M | 207.46M |
| Average Diluted Shares Outstanding | 208.94M | 207.76M | 207.53M | 207.27M | 209.18M |
| Dividend Per Share | -- | 0.00 | 0.00 | 0.00 | 0.26 |
| Payout Ratio | -- | -- | 41.71% | -- | -- |